• 更多栏目

    齐民

    • 教授     博士生导师   硕士生导师
    • 主要任职:Professor
    • 性别:男
    • 毕业院校:大连理工大学
    • 学位:博士
    • 所在单位:材料科学与工程学院
    • 学科:材料学. 生物医学工程
    • 办公地点:材料学院222房间
    • 联系方式:84708441
    • 电子邮箱:minqi@dlut.edu.cn

    访问量:

    开通时间:..

    最后更新时间:..

    Proteomic analysis of chondromodulin-I-induced differentiation of mesenchymal stem cells into chondrocytes

    点击次数:

    论文类型:期刊论文

    发表时间:2017-04-21

    发表刊物:Journal of proteomics

    收录刊物:PubMed

    卷号:159

    页面范围:1-18

    ISSN号:1876-7737

    关键字:ChM-I,Chondrocyte,MSCs,Proteome,Tissue engineering

    摘要:To identify novel proteins that might help clarify the molecular mechanisms underlying chondromodulin-I (ChM-I) induction of mesenchymal stem cells (MSCs) differentiate into chondrocytes. MSCs are triggered to differentiate into chondrocytes, which are recognized as important factors in cartilage tissue engineering. ChM-I is a glycoprotein that stimulates the growth of chondrocytes and inhibits angiogenesis in vitro. In this study, the proteomic approach was used to evaluate protein changes between undifferentiated MSCs and ChM-I-transfected MSCs. The expression of the protein spots was analyzed using two-dimensional gel electrophoresis. Then, 14 protein spots were identified between MSCs and ChM-I-transfected MSCs. 309 proteins were identified using mass spectrometry (MS). The differentially regulated proteins were categorized and annotated using Protein Analysis Through Evolutionary Relationships (PANTHER) analysis with the aid of the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool. These proteins are included in a variety of metabolic pathways and signal transduction pathways, such as focal adhesion, glycolysis, actin cytoskeleton regulation, and ribosome. These results demonstrate novel information about the molecular mechanism by which ChM-I induce MSCs to differentiate into chondrocytes. These results also provide a solid foundation for the development of tissue-engineered cartilage.Copyright © 2017 Elsevier B.V. All rights reserved.